Red Blood Cell Disorders Flashcards
Which Gene, which disease? –> Mutation results in replacement of glutamic acid by valine in position 6
Hemoglobin S
Beta globin
Hemoglobin S is what?
Beta Globin Gene mutation
*point mutation
*Mutation results in replacement of glutamic acid by valine in position 6
*6Glu–>Val
What do hemoglobin S and hemoglobin C have in common?
point mutations in the Beta Globin gene
*Hb S–> 6GLU-VAL
*Hb C–> 6GLU-LYS
You see Decreased Hgb A (50-60%), and presence of Hb S (35-45%) on HPLC…
Hemoglobin S TRAIT
*or transfused Hb SS
What is the Sickledex test
*(solubility test for Hgb S)
Lyses RBCs, then adds reducing agent
*Reduced Hb S is insoluble
Turbidity of reduced Hb S solution observed in positive tests
*Positive in BOTH sickle cell trait and sickle cell disease
What’s the most common hemoglobinopathy in the US?
*Hemoglobin S, and particularly Hb S TRAIT
*Most common hemoglobinopathy in United States
*Present in approximately 9% of African Americans
*Present in 25-45% of population in Western Africa
*Hemoglobin S thought to be protective against Plasmodium infection
How do Sickle cell TRAIT patients clinically present?
Patients are usually asymptomatic
*Rarely, symptoms can include vascular occlusion (infarcts) in hypoxic or acidotic conditions (e.g., chronic heart failure, plane travel, respiratory infections, anesthesia)
*Rarely, spontaneous sickling can occur in renal papillae, leading to papillary necrosis, hematuria, and impaired ability to concentrate urine
*Association with exercise-related sudden death and increased risk for renal medullary carcinoma
How do HPLC findings change when Hb S is co-inherited with another thalassemia?
If co-inherited with alpha-globin gene deletion(s), Hb S < 35%
If co-inherited with β⁺ thalassemia, percentage of Hb S > percentage of Hb A
If co-inherited with β⁰ thalassemia, almost all hemoglobin is Hb S, same phenotype as sickle cell disease (~ Hb SS)
What’s the sickle cell test?
*NOT sicledex!!!
Mixes patient blood and sodium metabisulfite
Deoxygenated red blood cells will sickle and be observed under microscope
Sickle cell disorder patients are at risk for which bacterial infections?
They have no functional spleen
*Increased susceptibility to Salmonella and pneumococci
What is Hemoglobin C disease?
*Mutation in 1 (“trait”) or both (“disease”) copies of β-globin gene results in substitution of glutamic acid → lysine in sixth amino acid
*Hb C is less soluble than Hb A and crystallizes within RBC
**Hb C crystallizes in oxygenated state as opposed to Hb S, which polymerizes in deoxygenated state
*RBC life span is decreased to 30-35 days
Peripheral blood smear with Hemoglobin C disease
Peripheral smear with target cells and in Hb CC polyhedral or rod-shaped “cigar-shaped” crystals (Hb C crystals)
What is Hb A2?
Hb A₂ (approximately 3%; α₂δ₂) in normal adults
*elevated when there are no or FEW Beta globin subunits
*Beta-Thal
*point mutations that make Beta globin into C or S will not have A2 elevations, they will have their own peaks
What is hemoglobin F?
Hb F (approximately 1%; α₂γ₂) in normal individuals
*increased HbF in Hb SS patients is a good prognostic indicator
What do you clinically expect in Hemoglobin C disease?
Hb C disease
Mild to moderate hemolytic anemia
Can have splenomegaly, gallstones
Crystals (rhomboid), target cells
HPLC has it’s own peak with reduced Hb A
Tricky thing about Hemoglobin C on acid electrophoresis
Appears identical to Hb EE on acid electrophoresis because Hb E migrates in same position
Expected blood smear of Hb SC disease
Sickle cells are not* typically identified
Numerous target cells
Some RBCs may contain precipitated Hb, but hexagonal or rod-shaped crystals associated with Hb CC are not seen
“Boat cells” (plump, angulated cells) are present
What’s the unique disease interplay between C and S in Hb SC disease?
C makes S worse
Presence of Hb C causes increased potassium and chloride transport out of cell
**Reduced potassium in red blood cells (RBCs) results in cell dehydration and concentration of Hb S that are thought to increase Hb polymerization
SC cells have decreased life span
***Approximately 27 days vs. 90-120 days for normal RBCs
Southeast Asians have an increased risk for what Alpha-Thal?
*NON-deletional
*(generally, Alpha-thal is a deletional problem, B-thal is point mutation problem)
Hemoglobin Constant Spring is the most common nondeletional α-thalassemia in Southeast Asia.
Hemoglobin Constant Spring
*type of non-deletional alpha thal
Hemoglobin Constant Spring is the most common nondeletional α-thalassemia in Southeast Asia.
*A point mutation in the stop codon of the α2-globin gene (TAA→CAA) leads to the addition of 31 amino acids to the end of the normal α-globin chain, which renders it unstable.
What are the lab findings in Hb CS?
Hemoglobin ‘Constant Spring’
*Hb CS can be missed by all laboratory testing methods due to this instability, which can decrease the variant to undetectable levels. The red cell indices in hemoglobin Constant Spring trait resemble deletional α-thalassemia trait. When coinherited with other α-thalassemia mutations, Hb CS can result in hemoglobin H disease or hemoglobin Bart’s.
*non-deletional Alpha-thalassemia
What does del/(-) Alpha3.7 mean?
This is the most common deletional α-thalassemia mutation.
*non-deletional is Hb CS
*another common DELETIONAL mutation is -αTHAI mutatio
What is meant by del(-) alpha THAI?
-αTHAI mutation is one of the more common deletional α-thalassemias.
What is meant by Hemoglobin Koya Dora?
Hemoglobin Koya Dora is a nondeletional α-thalassemia mutation, but it is not the most common in Southeast Asia.
What should you think if you see ALL hemoglobin is Hb A2?
**Hemoglobin E/β-thalassemia
*caused by double heterozygosity for β-thalassemia and the structural hemoglobin variant, Hgb E (G→A substitution in codon 26 of the β-globin gene).
β-Thalassemia results in no hemoglobin being produced from one of the β-globins, and the Hgb E mutation results in a structural variant that is also produced in decreased amounts (thalassemic structural variant). This hemoglobinopathy is found predominantly in Southeast Asia (particularly in Thailand, Laos, and Cambodia). The phenotype is highly variable and can present from mild anemia to transfusion-dependent anemia